Journal of Adolescent Health
Volume 40, Issue 2 , Pages 173-179 , February 2007

Medical Conditions of Adolescents in Alcohol and Drug Treatment: Comparison with Matched Controls

  • Jennifer R. Mertens, M.A.

      Affiliations

    • Kaiser Permanente Northern California, Division of Research, Oakland, California
    • Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa
    • Corresponding Author InformationAddress correspondence to: Ms. Jennifer Mertens, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, 3rd Floor, Oakland, CA 94612-2304.
    • ,
  • Alan J. Flisher, M.B.Ch.B.

      Affiliations

    • Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa
    • Adolescent Health Research Institute, University of Cape Town, Cape Town, South Africa
    • ,
  • Michael F. Fleming, M.D.

      Affiliations

    • Department of Family Medicine, University of Wisconsin, Madison, Wisconsin
    • ,
  • Constance M. Weisner, Dr.P.H.

      Affiliations

    • Kaiser Permanente Northern California, Division of Research, Oakland, California
    • Department of Psychiatry, University of California, San Francisco, California

Received 29 April 2006 ,Accepted 21 September 2006.

References 

  1. Mertens JR, Lu YW, Parthasarathy S, et al. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med. 2003;163:2511–2517
  2. Weisner C, Mertens J, Parthasarathy S, et al. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286:1715–1723
  3. Grant BF, Dawson DA. Alcohol and drug use, abuse, and dependence: classification, prevalence, and comorbidity. In:  McCrady BS,  Epstein EE editor. Addictions: A Comprehensive Guidebook. New York, NY: Oxford University Press; 1999;p. 9–29
  4. Sterling S, Weisner C. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res. 2005;25:801–809
  5. Arria AM, Dohey MA, Mezzich AC, et al. Self-reported health problems and physical symptomatology in adolescent alcohol abusers. J Adolesc Health. 1995;16:226–231
  6. Aarons GA, Brown SA, Coe MT, et al. Adolescent alcohol and drug abuse and health. J Adolesc Health. 1999;24:412–421
  7. Clark DB, Lynch KG, Donovan JE, et al. Health problems in adolescents with alcohol use disorders: self-report, liver injury, and physical examination findings and correlates. Alcohol Clin Exp Res. 2001;25:1350–1359
  8. Shrier LA, Harris SK, Sternberg M, et al. Associations of depression, self-esteem, and substance use with sexual risk among adolescents. Prev Med. 2001;33:179–189
  9. Berenson AB, Wiemann CM, McCombs S. Exposure to violence and associated health-risk behaviors among adolescent girls. Arch Pediatr Adolesc Med. 2001;155:1238–1242
  10. Centers for Disease Control and Prevention. Human immunodeficiency virus infection in the United States: a review of current knowledge. MMWR. 1987;36(suppl 6):1–20
  11. Lamminpaa A. Alcohol intoxication in childhood and adolescence. Alcohol Alcohol. 1995;30:5–12
  12. Schwartz RH, Luxenberg MG, Hoffmann NG. “Crack” use by American middle-class adolescent polydrug abusers. J Pediatr. 1991;118:150–155
  13. Madianos MG, Madianou-Gefou D, Stefanis CN. Drug use and somatic illnesses with psychological component: a nation-wide survey among adolescents and adults in Greece. Psychother Psychosom. 1993;60:177–185
  14. Albertson TE, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. West J Med. 1999;170:214–219
  15. Richards JR, Johnson EB, Stark RW, et al. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med. 1999;17:681–685
  16. Weisner C, Mertens J, Parthasarathy S, et al. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. Health Serv Res. 2000;35:791–812
  17. Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA. 1991;265:1152–1154
  18. Schneir A, Manoguerra AS. Medical consequences of the use of cocaine and other stimulants. In:  Brick J editors. Handbook of the Medical Consequences of Alcohol and Drug Abuse. New York, NY: Haworth Press; 2004;p. 257–279
  19. Carroll A, Houghton S, Odgers P. Volatile solvent use among Western Australian adolescents. Adolescence. 1998;33:877–889
  20. Stein MD. Medical consequences of substance abuse. Psychiatr Clin North Am. 1999;22:351–370
  21. In:  Brick J editors. Handbook of the Medical Consequences of Alcohol and Drug Abuse. New York, NY: Haworth Press, Inc; 2004;
  22. Wollina U, Kammler HJ, Hesselbarth N, et al. Ecstasy pimples: a new facial dermatosis. Dermatology. 1998;197:171–173
  23. Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. Can Med Assoc J. 2001;165:917–928
  24. Freese TE, Miotto K, Reback CJ. The effects and consequences of selected club drugs. J Subst Abuse Treat. 2002;23:151–156
  25. Allison KW, Crawford I, Leone PE, et al. Adolescent substance use: preliminary examinations of school and neighborhood context. Am J Community Psychol. 1999;27:111–141
  26. De Bellis MD, Clark DB, Beers SR, et al. Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry. 2000;157:737–744
  27. Reneman L, Booij J, de Bruin K, et al. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 2001;358:1864–1869
  28. Reid A, Lynskey M, Copeland J. Cannabis use among Australian adolescents: findings of the 1998 National Drug Strategy Household Survey. Aust N Z J Public Health. 2000;24:596–602
  29. Sterling S, Kohn CS, Lu Y, et al. Pathways to substance abuse treatment for adolescents in an HMO. J Psychoactive Drugs. 2004;36:439–453
  30. Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001;161:85–91
  31. Morris JA. Alcohol and other drug dependency treatment: a proposal for integration with primary care. Alcohol Treat Q. 1995;13:45–46
  32. Levin SM, Trumble JG, Edmunds M, et al. Perspectives on linkage of primary health care and substance abuse treatment. J Addict Dis. 1993;12:1–8
  33. Gordon NP. Characteristics of Adult Health Plan Members in the Northern California Region Membership, as Estimated from the 1999 Member Health Survey. Oakland, CA: Division of Research, Northern California Region, Kaiser Permanente Medical Care Program; 2000;
  34. Jewell NP. Statistics for Epidemiology. New York, NY: Chapman & Hall; 2004;
  35. Selby JV. Linking automated databases for research in managed care settings. Ann Intern Med. 1997;127:719–724
  36. Ray GT, Collin F, Lieu T, et al. The cost of health conditions in a health maintenance organization. Med Care Res Rev. 2000;57:92–109
  37. Meyers K, McLellan AT, Jaeger J, et al. The development of the comprehensive adolescent addiction severity index (CAASI): An interview for assessing multiple problems of adolescents. J Subst Abuse Treat. 1995;12:181–193
  38. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43–46
  39. Thatcher DL, Clark DB. Cardiovascular risk factors in adolescents with alcohol use disorders. Int J Adolesc Med Health. 2006;18:151–157
  40. White KS, Farrell AD. Anxiety and psychosocial stress as predictors of headache and abdominal pain in urban early adolescents. J Pediatr Psychol. 2005;31:582–596

PII: S1054-139X(06)00369-7

doi: 10.1016/j.jadohealth.2006.09.021

Journal of Adolescent Health
Volume 40, Issue 2 , Pages 173-179 , February 2007

Article Tools